Announcements Trials
Browse Landscape

Phase

Phase 2 55Phase 1 15Phase 1/2 9Phase EARLY_PHASE1 2Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 119Thoracic 46Gynecologic 42Breast 32CNS 15Genitourinary 10Tumor-Agnostic 5Sarcoma 2Other solid neoplasm 1NET 1Lymphoid 1Head & Neck 1Endocrine 1Classical hematology 1

Conditions

Gliosarcoma 1Glioblastoma 1Gastrointestinal Stromal Tumors 1

Interventions

Doxorubicin 40Radiotherapy 30Ifosfamide 28Vincristine 27Cyclophosphamide 24Imatinib Mesylate 20Etoposide 20Dactinomycin 14Radiation 13Filgrastim 11Temozolomide 9Sunitinib 9Trabectedin 8Methotrexate 8Specimen Handling 7Magnetic Resonance Spectroscopy 6Granulocyte Colony-Stimulating Factor 6Chemotherapy, Adjuvant 6pazopanib 5nilotinib 5Zoledronic Acid 5Neoadjuvant Therapy 5Irinotecan 5Cisplatin 5Carboplatin 5X-Rays 4Vinorelbine 4Topotecan 4Surgical Procedures, Operative 4Procarbazine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Bevacizumab × Sarcoma × Clear all
NCT00884741 2019-07-24

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

National Cancer Institute (NCI)

Phase 3 Completed
637 enrolled 11 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00324987 2017-09-14

S0502

National Cancer Institute (NCI)

Phase 3 Terminated
12 enrolled 13 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡